141 related articles for article (PubMed ID: 7104962)
1. Ascites in agnogenic myeloid metaplasia: association with peritoneal implant of myeloid tissue and therapy.
Patel NM; Kurtides ES
Cancer; 1982 Sep; 50(6):1189-90. PubMed ID: 7104962
[TBL] [Abstract][Full Text] [Related]
2. Secondary myelofibrosis with metastatic breast cancer simulating agnogenic myeloid metaplasia: report of a case and review of the literature.
Yablonski-Peretz T; Sulkes A; Polliack A; Weshler Z; Okon E; Catane R
Med Pediatr Oncol; 1985; 13(2):92-6. PubMed ID: 3982370
[TBL] [Abstract][Full Text] [Related]
3. [Postpolycythemic myeloid metaplasia in patients with polycythemia vera].
Spasojević J; Pejin D; Stajnic S
Med Pregl; 1997; 50(5-6):224-8. PubMed ID: 9297056
[TBL] [Abstract][Full Text] [Related]
4. Ascites revealing peritoneal and hepatic extramedullary hematopoiesis with peliosis in agnogenic myeloid metaplasia: case report and review of the literature.
Lioté F; Yeni P; Teillet-Thiebaud F; Barge J; Devars Du Mayne JF; Flamant Y; Molas G; Carbon C
Am J Med; 1991 Jan; 90(1):111-7. PubMed ID: 1986577
[TBL] [Abstract][Full Text] [Related]
5. Subdural hemorrhage secondary to extramedullary hematopoiesis in postpolycythemic myeloid metaplasia.
Brown JA; Gomez-Leon G
Neurosurgery; 1984 May; 14(5):588-91. PubMed ID: 6728168
[TBL] [Abstract][Full Text] [Related]
6. Ectopic medullary hematopoiesis as a cause of ascites in agnogenic myeloid metaplasia. Case report and review of the literature.
Knobel B; Melamud E; Virag I; Meytes D
Acta Haematol; 1993; 89(2):104-7. PubMed ID: 8503241
[TBL] [Abstract][Full Text] [Related]
7. Agnogenic myeloid metaplasia in children.
Mallouh AA; Sa'di AR
Am J Dis Child; 1992 Aug; 146(8):965-7. PubMed ID: 1636666
[TBL] [Abstract][Full Text] [Related]
8. Prognostic parameters in myeloid metaplasia: agnogenic versus postpolycythemic.
Meytes D; Katz D; Ramot B
Isr J Med Sci; 1976 Jun; 12(6):534-42. PubMed ID: 955869
[TBL] [Abstract][Full Text] [Related]
9. Primary (essential) thrombocythemia versus initial (hyperplastic) stages of agnogenic myeloid metaplasia with thrombocytosis--a critical evaluation of clinical and histomorphological data.
Thiele J; Zankovich R; Steinberg T; Kremer B; Fischer R; Diehl V
Acta Haematol; 1989; 81(4):192-202. PubMed ID: 2474228
[TBL] [Abstract][Full Text] [Related]
10. Hepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myeloid metaplasia: a clinicopathological study of 145 patients examined at autopsy.
Wanless IR; Peterson P; Das A; Boitnott JK; Moore GW; Bernier V
Hepatology; 1990 Nov; 12(5):1166-74. PubMed ID: 2227815
[TBL] [Abstract][Full Text] [Related]
11. Polycythaemia after myeloid metaplasia with fibrosis: an unusual sequence.
Gardais J; Suraniti S; Fressinaud P
Haematologica; 1992; 77(5):433-4. PubMed ID: 1483596
[TBL] [Abstract][Full Text] [Related]
12. Acute myelofibrosis: a report of three cases.
Fabich DR; Raich PC
Am J Clin Pathol; 1977 Apr; 67(4):334-8. PubMed ID: 851094
[TBL] [Abstract][Full Text] [Related]
13. Polycythemia vera. II. Transgression towards leukemia with special emphasis on histological differential diagnosis, cytogenetics and survival.
Vykoupil KF; Thiele J; Stangel W; Krmpotic E; Georgii A
Virchows Arch A Pathol Anat Histol; 1980; 389(3):325-41. PubMed ID: 6935867
[No Abstract] [Full Text] [Related]
14. Post-polycythemia myeloid metaplasia: experience with a large cohort of patients.
Randi ML; Barbone E; Fabris F; Varotto L; Macri C; Girolami A
J Med; 1994; 25(6):363-9. PubMed ID: 7769374
[TBL] [Abstract][Full Text] [Related]
15. Agnogenic myeloid metaplasia.
Block M
Rev Bras Pesqui Med Biol; 1974; 7(2):185-95. PubMed ID: 4527643
[No Abstract] [Full Text] [Related]
16. Development of polycythemia vera in a patient with myeloid metaplasia and myelofibrosis. Report of a case with a comment on its significance in relation to prevailing views on myeloid metaplasia.
Hershko C; Polliack A
Isr J Med Sci; 1971 Feb; 7(2):315-20. PubMed ID: 5560987
[No Abstract] [Full Text] [Related]
17. Reversal of bone marrow fibrosis and subsequent development of polycythemia in patients with myeloproliferative disorders.
Talarico L; Wolf BC; Kumar A; Weintraub LR
Am J Hematol; 1989 Apr; 30(4):248-53. PubMed ID: 2929585
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic value of bone and bone marrow lesions of primary myeloid metaplasia].
Chelloul N; Jacquillat C; Brière J; Laval-Jeantet M; Vorhauer-Atlan W
Nouv Presse Med; 1975 Dec; 4(43):3060-2. PubMed ID: 1223788
[TBL] [Abstract][Full Text] [Related]
19. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
Tefferi A
Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
[TBL] [Abstract][Full Text] [Related]
20. Agnogenic myelofibrosis in children--a case report and review of the literature.
Hamazaki M; Mugishima H
Acta Pathol Jpn; 1981 Jan; 31(1):143-52. PubMed ID: 7234418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
